JP2000511771A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511771A5
JP2000511771A5 JP1997537532A JP53753297A JP2000511771A5 JP 2000511771 A5 JP2000511771 A5 JP 2000511771A5 JP 1997537532 A JP1997537532 A JP 1997537532A JP 53753297 A JP53753297 A JP 53753297A JP 2000511771 A5 JP2000511771 A5 JP 2000511771A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997537532A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511771A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA1997/000265 external-priority patent/WO1997040063A2/en
Publication of JP2000511771A publication Critical patent/JP2000511771A/ja
Publication of JP2000511771A5 publication Critical patent/JP2000511771A5/ja
Ceased legal-status Critical Current

Links

JP09537532A 1996-04-23 1997-04-23 病原性大腸菌関連タンパク質 Ceased JP2000511771A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1599996P 1996-04-23 1996-04-23
US60/015,999 1996-04-23
PCT/CA1997/000265 WO1997040063A2 (en) 1996-04-23 1997-04-23 Pathogenic escherichia coli associated protein espa

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008233530A Division JP5058106B2 (ja) 1996-04-23 2008-09-11 病原性大腸菌関連タンパク質

Publications (2)

Publication Number Publication Date
JP2000511771A JP2000511771A (ja) 2000-09-12
JP2000511771A5 true JP2000511771A5 (https=) 2004-12-09

Family

ID=21774805

Family Applications (3)

Application Number Title Priority Date Filing Date
JP09537532A Ceased JP2000511771A (ja) 1996-04-23 1997-04-23 病原性大腸菌関連タンパク質
JP2008233530A Expired - Fee Related JP5058106B2 (ja) 1996-04-23 2008-09-11 病原性大腸菌関連タンパク質
JP2010043983A Pending JP2010132698A (ja) 1996-04-23 2010-03-01 病原性大腸菌関連タンパク質

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008233530A Expired - Fee Related JP5058106B2 (ja) 1996-04-23 2008-09-11 病原性大腸菌関連タンパク質
JP2010043983A Pending JP2010132698A (ja) 1996-04-23 2010-03-01 病原性大腸菌関連タンパク質

Country Status (10)

Country Link
US (4) US6355254B1 (https=)
EP (1) EP0904288B1 (https=)
JP (3) JP2000511771A (https=)
KR (1) KR20000010667A (https=)
AU (1) AU2562897A (https=)
BR (1) BR9710433A (https=)
CA (1) CA2252372C (https=)
DK (1) DK0904288T3 (https=)
ES (1) ES2389625T3 (https=)
WO (1) WO1997040063A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252438C (en) * 1996-04-19 2011-03-29 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
BR9710433A (pt) 1996-04-23 1999-10-05 Univ British Columbia Proteínas associada a escherichia coli patogênica
US6204004B1 (en) * 1997-03-21 2001-03-20 University Of Maryland, Baltimore Immunodiagnostic test for enterohemorrhagic Escherichia coli infection
US7208574B1 (en) 1997-11-12 2007-04-24 The University Of British Columbia Host receptor for pathogenic bacteria
WO1999045136A1 (en) * 1998-03-05 1999-09-10 University Of British Columbia Methods for assaying type iii secretion inhibitors
US6342352B1 (en) 1998-04-24 2002-01-29 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of detecting shigella and shigella mxiM DNA
US6136542A (en) * 1998-05-13 2000-10-24 Institut Pasteur Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria
US6696249B1 (en) 1998-05-13 2004-02-24 Institut Pasteur Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria
WO2001073440A2 (de) * 2000-03-28 2001-10-04 Schebo Biotech Ag Nachweis von diarrhogenen e.coli-keimen
AU2002218927B2 (en) 2001-01-04 2007-08-30 The University Of British Columbia Enterohemorrhagic Escherichia coli vaccine
CA2339436A1 (fr) 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
US20060241075A1 (en) * 2001-05-18 2006-10-26 Sirna Therapeutics, Inc. RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA)
WO2004050119A1 (en) * 2002-11-29 2004-06-17 Imperial College Innovations Limited Vaccine against enteropathogenic and enterohaemorragic escherichia coli
BRPI0415816A (pt) 2003-10-31 2006-12-26 Univ British Columbia composição, bactéria ou um preparado da mesma, método para detectar a presença de um patógeno de a/e em uma amostra, método para provocar uma resposta imunológica contra um patógeno de a/e ou um componente do mesmo em um animal, método para reduzir a colonização de um patógeno de a/e em um animal, método para reduzir a disseminação de um patógeno de a/e em um animal, método para o tratamento ou a prevenção da infecção por um patógeno de a/e, método para atenuar a virulência de um patógeno de a/e, método para a seleção de um composto que atenue a virulência de um patógeno e a/e, método para a produção de um polipeptìdio de patógeno de a/e, polipeptìdio recombinante, molécula de ácido nucléico isolada, vetor, célula hospedeira, uso da composição e kit
GB0411624D0 (en) * 2004-05-25 2004-06-30 Imp College Innovations Ltd Products and uses thereof
JP5151477B2 (ja) 2005-04-28 2013-02-27 日立金属株式会社 半導体磁器組成物とその製造方法
WO2008133659A2 (en) 2006-11-29 2008-11-06 Tufts University Eschericia coli mutants and methods of use thereof
WO2009032978A2 (en) * 2007-09-07 2009-03-12 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating urinary tract infections
JP2012522522A (ja) 2009-04-06 2012-09-27 ユニバーシティー オヴ サスカチュワン 志賀毒素産生大腸菌感染を処置及び予防するための方法並びに組成物
US20110229512A1 (en) * 2010-03-19 2011-09-22 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating urinary tract infections
JP5714692B2 (ja) * 2010-03-23 2015-05-07 イーエムベーアー−インスティトゥート・フューア・モレクラレ・ビオテヒノロギー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングImba−Institut Fuermolekulare Biotechnologie Gmbh Iii型分泌機構の阻害剤の同定方法
GB201621686D0 (en) * 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US15999A (en) 1856-10-28 Improved projectile for ordnance
CA2078716A1 (en) 1992-09-21 1994-03-22 Joyce De Azavedo Attaching and effacing protein of enterohemorrhagic e. coli
US6090623A (en) * 1993-08-11 2000-07-18 Merck & Co., Inc. Recombinant human calcium channel β4 subunits
BR9710433A (pt) * 1996-04-23 1999-10-05 Univ British Columbia Proteínas associada a escherichia coli patogênica

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2000501599A5 (https=)
JP2001503840A5 (https=)
JP2000501018A5 (https=)
JP2000501324A5 (https=)
JP2000504400A5 (https=)
JP2000500026A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2000501338A5 (https=)
JP2000500874A5 (https=)
JP2000507722A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000502568A5 (https=)
JP2000504186A5 (https=)
JP2000501774A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000503849A5 (https=)
JP2000501744A5 (https=)
JP2000501229A5 (https=)
JP2000502316A5 (https=)